These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35741597)

  • 1. Prognosis of Guillain-Barré Syndrome Linked to COVID-19 Vaccination.
    Chua SKK; Soh QY; Saffari SE; Tan EK
    Brain Sci; 2022 May; 12(6):. PubMed ID: 35741597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world data on the incidence and risk of Guillain-Barré syndrome following SARS-CoV-2 vaccination: a prospective surveillance study.
    Ha J; Park S; Kang H; Kyung T; Kim N; Kim DK; Kim H; Bae K; Song MC; Lee KJ; Lee E; Hwang BS; Youn J; Seok JM; Park K
    Sci Rep; 2023 Mar; 13(1):3773. PubMed ID: 36882454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guillain-Barre syndrome following COVID-19 vaccines: A review of literature.
    Yu M; Nie S; Qiao Y; Ma Y
    Front Immunol; 2023; 14():1078197. PubMed ID: 36875094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine-related Guillain-Barré syndrome in the Liguria region of Italy: A multicenter case series.
    Germano F; Bellucci M; Grisanti S; Beronio A; Grazzini M; Coco E; Tassinari T; Della Cava F; De Michelis C; Baldi O; Sivori G; Murialdo A; Cabona C; Durando P; Uccelli A; Schenone A; Franciotta D; Benedetti L
    J Neurol Sci; 2022 Sep; 440():120330. PubMed ID: 35802961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine hesitancy with a history of Guillain Barre Syndrome: Weighing the risks and benefits of SARS-CoV-2 vaccination.
    Murawska Baptista A; Alok A; Libertin C
    IDCases; 2022; 28():e01467. PubMed ID: 35284232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barré syndrome in association with COVID-19 vaccination: a systematic review.
    Abolmaali M; Rezania F; Behnagh AK; Hamidabad NM; Gorji A; Mirzaasgari Z
    Immunol Res; 2022 Dec; 70(6):752-764. PubMed ID: 36098903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series.
    Nagdev G; Chavan G; Sahu G; Devasilpa Raju PD
    Cureus; 2022 Oct; 14(10):e30888. PubMed ID: 36465787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Guillain-Barré Syndrome After COVID-19 Vaccination in the Vaccine Safety Datalink.
    Hanson KE; Goddard K; Lewis N; Fireman B; Myers TR; Bakshi N; Weintraub E; Donahue JG; Nelson JC; Xu S; Glanz JM; Williams JTB; Alpern JD; Klein NP
    JAMA Netw Open; 2022 Apr; 5(4):e228879. PubMed ID: 35471572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2.
    Leung C
    Hum Vaccin Immunother; 2021 Sep; 17(9):2957-2958. PubMed ID: 34032555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-COVID-19 vaccine Guillain-Barré syndrome; first reported case from Qatar.
    Razok A; Shams A; Almeer A; Zahid M
    Ann Med Surg (Lond); 2021 Jul; 67():102540. PubMed ID: 34249353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome after COVID-19 vaccination.
    McKean N; Chircop C
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34330729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
    Acharya B; Kc S; Karki S; Thapa P; Kc P
    Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases.
    Kim JE; Min YG; Shin JY; Kwon YN; Bae JS; Sung JJ; Hong YH
    Front Neurol; 2021; 12():820723. PubMed ID: 35153993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reports of Guillain-Barre Syndrome Following COVID-19 Vaccination in the USA: An Analysis of the VAERS Database.
    Chalela JA; Andrews C; Bashmakov A; Kapoor N; Snelgrove D
    J Clin Neurol; 2023 Mar; 19(2):179-185. PubMed ID: 36854334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barre syndrome following COVID-19 vaccines: A scoping review.
    Lahoz Fernandez PE; Miranda Pereira J; Fonseca Risso I; Baleeiro Rodrigues Silva P; Freitas Barboza IC; Vieira Silveira CG; Diogo Silva G; Marzorati Kuntz Puglia P; Genaro Mutarelli E
    Acta Neurol Scand; 2022 Apr; 145(4):393-398. PubMed ID: 34967005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post SARS-CoV-2 vaccination Guillain-Barre syndrome in 19 patients.
    Finsterer J; Scorza FA; Scorza CA
    Clinics (Sao Paulo); 2021; 76():e3286. PubMed ID: 34644738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barre syndrome 15 days after COVID-19 despite SARS-CoV-2 vaccination.
    Finsterer J
    IDCases; 2021; 25():e01226. PubMed ID: 34290962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review.
    Aladawi M; Elfil M; Abu-Esheh B; Abu Jazar D; Armouti A; Bayoumi A; Piccione E
    Can J Neurol Sci; 2022 Jan; 49(1):38-48. PubMed ID: 33949300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.